Get started
Author

Stefanie Porkert

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
2015 · Julia J. Scarisbrick, H. Miles Prince, et al. · Journal of Clinical Oncology · 450
PDF
The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients
2018 · J.J. Scarisbrick, P. Quaglino, et al. · British Journal of Dermatology · 248
PDF
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium
2017 · P. Quaglino, M. Maule, et al. · Annals of Oncology · 140
PDF
Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index ( PROCLIPI ) study
2019 · K. Molloy, C. Jonak, et al. · British Journal of Dermatology · 123
PDF
Evaluation of Low-Dose, Low-Frequency Oral Psoralen–UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides: A Randomized Clinical Trial
2019 · Pablo Vieyra-Garcia, Regina Fink-Puches, et al. · JAMA Dermatology · 54
PDF
Single-Cell RNA Sequencing Reveals Tissue Compartment-Specific Plasticity of Mycosis Fungoides Tumor Cells
2021 · Katharina Rindler, Wolfgang M. Bauer, et al. · Frontiers in Immunology · 51
PDF
A Prospective Study of Mobile Phones for Dermatology in a Clinical Setting
2013 · Jessika Weingast, Christian Scheibböck, et al. · Journal of Telemedicine and Telecare · 42
Patients' Illness Perception as a Tool to Improve Individual Disease Management in Primary Cutaneous Lymphomas
2017 · S Porkert, E Lehner-Baumgartner, et al. · Acta Dermato Venereologica · 41
PDF
Health-related Quality of Life in Cutaneous Lymphomas: Past, Present and Future
2019 · C Jonak, S Porkert, et al. · Acta Dermato Venereologica · 36
PDF
The changing epidemiology of human leishmaniasis in the non-endemic country of Austria between 2000 to 2021, including a congenital case
2024 · Katharina Riebenbauer, Stefan Czerny, et al. · PLoS neglected tropical diseases · 34
PDF
Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity*
2021 · E. Papadavid, E. Kapniari, et al. · British Journal of Dermatology · 31
Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study
2020 · M.‐C. Brüggen, J. Valencak, et al. · Journal of the European Academy of Dermatology and Venereology · 28
PDF
Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study
2024 · Keila Mitsunaga, Martine Bagot, et al. · British Journal of Dermatology · 27
Corrections to “Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium”
2018 · P. Quaglino, M. Maule, et al. · Annals of Oncology · 27
PDF
Single‐cell RNA sequencing profiling in a patient with discordant primary cutaneous B‐cell and T‐cell lymphoma reveals micromilieu‐driven immune skewing
2021 · C. Jonak, N. Alkon, et al. · British Journal of Dermatology · 20
PDF
Quality of Life, Anxiety, and Depression in Patients With Early-Stage Mycosis Fungoides and the Effect of Oral Psoralen Plus UV-A (PUVA) Photochemotherapy on it
2020 · Thomas Graier, Regina Fink-Puches, et al. · Frontiers in Medicine · 19
PDF
Long-term Therapeutic Success of Intravenous Rituximab in 26 Patients with Indolent Primary Cutaneous B-cell Lymphoma
2021 · S Porkert, P Mai, et al. · Acta Dermato Venereologica · 13
Comparing functional and genomic‐based precision medicine in blood cancer patients
2025 · Lukas Kazianka, Alexander Pichler, et al. · HemaSphere · 8
PDF
Real-world study of the use of pegylated interferon alfa for treatment of primary cutaneous T-cell lymphomas: an EORTC CLTF study
2022 · K Mitsunaga, M Bagot, et al. · European Journal of Cancer · 5
Mycosis fungoides/Sézary syndrome and systemic Janus kinase inhibitors: a real-world retrospective study on behalf of the EORTC CLTG
2026 · Iris Amitay-Laish, Keila Mitsunaga, et al. · British Journal of Dermatology · 4
The diagnosis of early‐stage mycosis fungoides: Views held by experts and non‐experts in cutaneous lymphoma
2025 · Paula Beatty, Kevin Molloy, et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 4
Evaluation of mortality, prognostic parameters, and treatment efficacy in mycosis fungoides
2024 · Stefanie Porkert, Johannes Griss, et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 3
PDF
Indolent primary cutaneous B-cell lymphomas resemble persistent antigen reactions without signs of dedifferentiation
2026 · Johannes Griss, Sabina Gansberger, et al. · Nature Communications · 2
Cutaneous lymphomas—fast facts about an orphan disease—a short review
2023 · Stefanie Porkert, Julia Valencak · memo - Magazine of European Medical Oncology · 2
PDF
Ropeginterferon-α2b in Mycosis fungoides and Sézary Syndrome: Safety and Efficacy in 41 Patients
2025 · Stefanie Porkert, Juliette M. Kersten, et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 1
PDF
Works count: 47
Citation count: 1,418
H-index: 16
I10-index: 17
Year
Topic
Type